$BMSN -- OUR APPROACH | REGEN BIOPHARMA, INC.
Post# of 102233
$BMSN -- OUR APPROACH | REGEN BIOPHARMA, INC.
Regen BioPharma has assessed over 20,000 stem cell related issued patents, narrowed down to 2000 patents with commercial applicability, and further identified 30 patents available for licensing. The company seeks to inlicense, take the product to, and through clinical safety and efficacy "signal" and spin out technologies.